Back

Improved cardiac function by medium-chain triacylglycerol intake links to increased fat and ketone body availability

31 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Josephine Maria Kanta

University of Copenhagen, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Functional phenotyping combined with single-cell sequencing unmasks potential genes for hypercontractility in murine HFpEF
Mr T. Jeising (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Nuclear receptor co-repressor 1 promotes macrophage inflammation in heart failure with preserved ejection fraction: a translational study
Doctor E. Gorica (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cell-type specific secretome profiling reveals targets of liver-heart interorgan crosstalk in HFpEF and semaglutide treatment
Doctor J. Schuette (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Disease-associated characteristics of cardiac endothelial cells and fibroblasts from a cardiomyocyte specific transgenic murine heart failure model
Mrs C. Redwanz (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Establishment of a female HFpEF model using Dahl salt-sensitive rats and investigation of sympathetic activation-induced acute exacerbation of HFpEF
Doctor H. Nakashima (Fukuoka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of exogenous ketone supplementation on cardiac energetics, function, and perfusion in type 2 diabetes, heart failure, and healthy participants- A single center, open labelled clinical study.
thumbnail
Congress Presentation
Acute hemodynamic effect of oral ketones in patients with acutely decompensated heart failure and low cardiac output syndrome: a prospective randomized study.
thumbnail
Congress Presentation
Metabolic effects of 14-day oral ketone ester treatment in patients with heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources